Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 3376 - 3400 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ▼ ChEBI ID Exact Mass Formula
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR03
  • Cytolipin R(d18:1/20:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261574 1282.812543 C64H118N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR02
  • Cytolipin R(d18:1/18:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261573 1254.781243 C62H114N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR01
  • Cytolipin R(d18:1/16:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261572 1226.749943 C60H110N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ08
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • Isoglobotriglycosylceramide(d18:1/26:1(17Z))
44261571 1161.811419 C62H115NO18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ07
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • Isoglobotriglycosylceramide(d18:1/24:1(15Z))
44261570 1133.780119 C60H111NO18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ06
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Isoglobotriglycosylceramide(d18:1/26:0)
44261569 73269 1163.827069 C62H117NO18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ05
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • Isoglobotriglycosylceramide(d18:1/24:0)
44261568 52616 1135.795769 C60H113NO18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ04
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Isoglobotriglycosylceramide(d18:1/22:0)
44261567 1107.764469 C58H109NO18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ03
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • Isoglobotriglycosylceramide(d18:1/20:0)
44261566 1079.733169 C56H105NO18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ02
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • Isoglobotriglycosylceramide(d18:1/18:0)
44261565 1051.701869 C54H101NO18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ01
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Isoglobotriglycosylceramide(d18:1/16:0)
44261564 1023.670569 C52H97NO18
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY08
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261563 1819.059438 C88H158N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY07
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261562 1791.028138 C86H154N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY06
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261561 1821.075088 C88H160N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY05
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261560 1793.043788 C86H156N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY04
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261559 1765.012488 C84H152N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY03
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261558 1736.981188 C82H148N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY02
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261557 1708.949888 C80H144N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261556 1680.918588 C78H140N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV08
  • Gala 1-3Lex(d18:1/26:1(17Z))
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261555 1673.001528 C82H148N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV07
  • Gala 1-3Lex(d18:1/24:1(15Z))
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261554 1644.970228 C80H144N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV06
  • Gala 1-3Lex(d18:1/26:0)
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261553 1675.017178 C82H150N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV05
  • Gala 1-3Lex(d18:1/24:0)
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261552 1646.985878 C80H146N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV04
  • Gala 1-3Lex(d18:1/22:0)
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261551 1618.954578 C78H142N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV03
  • Gala 1-3Lex(d18:1/20:0)
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261550 1590.923278 C76H138N2O32

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024